Oncolytic immunotherapies specialist Replimune Group has announced that the US Food and Drug Administration (FDA) has ...
Summit Therapeutics (Nasdaq: SMMT) said it plans to file a biologics license application in the fourth quarter for ...
South Korea-based Samsung Bioepis and Chinese biotech start-up Phrontline Biopharma have entered into a global collaboration ...
US trade group the Research and Manufacturers of America (PhRMA) has hailed the impact of direct purchase programs (DPPs), ...
Swiss pharma giant Roche’s US subsidiary Genentech yesterday revealed that the US Food and Drug Administration (FDA) has ...
US contract manufacturer Life Science Outsourcing has appointed Doug Constable as chief executive to steer its next growth ...
Five months after closing its Series B financing, USA-based NewLimit has raised an additional $45 million from Eli Lilly), ...
South Korea’s SK Biopharmaceuticals (KRX: 326030) has partnered with Brazil’s Eurofarma to launch Mentis Care, a ...
Israeli pharma major Teva (NYSE: TEVA) has entered a licensing agreement with Singapore-based Prestige Biopharma (KOSDAQ: ...
Following an extensive review, Belgian biotech Galapagos today revealed its intention to wind down its cell therapy business ...
California, USA-based Alto Neuroscience saw its shares shoot up more than 80% to $11.00 yesterday, after it revealed it has ...
German Merck KGaA’s recently acquired subsidiary SpringWorks Therapeutics today announced that long-term efficacy and safety data from the Phase III DeFi trial of Ogsiveo (nirogacestat) were in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback